Tag: efficacy
-
Asbestos cancer study casts doubts on approved therapies efficacy
A study published in ‘Jama Network Open’ casts doubts on therapies approved as first-line treatment of malignant pleural mesothelioma (MPM), a severe form of cancer related to exposure to asbestos. The authors of the work are scientists of the American Sbarro Health Research Organization (Shro), of the Italian Mesothelioma Group (Gime) and of the Department…
-
Covid today Italy and vaccine, Iss: with booster 92% efficacy against severe disease
Covid today in Italy, intensive care and no vax, vaccine and dose booster. The effectiveness of the vaccine in preventing cases of severe Covid-19 disease is 85% in vaccinated with a full course of less than 90 days, 88% in vaccinated with a full course of 91 and 120 days., and 82% in vaccinated individuals…
-
Covid today Italy, Iss: possible efficacy of anti-HIV drug on viruses
Against Covid-19 it could have Cobicistat, a drug used in HIV / AIDS therapy, is effective. This was announced by the Higher Institute of Health, reporting the results of a study – currently conducted only in vitro and in an animal model – published by an international group of researchers in ‘mBio’, a journal of…
-
Coronavirus Why can an adult with coronary heart disease get a third vaccine when it is not actually recommended? – THL briefing on vaccine efficacy at 5 p.m.
THL answers public questions about the effectiveness of coronary vaccines on Tuesday at 5 p.m. HS looks at the opportunity live in this article. Already one in three residents of the Helsinki and Uusimaa Hospital District (Hus) area may have been infected with microscopy, the chief infectious disease doctor estimates Asko Järvinen last week. The…
-
Surprising new results on omicron efficacy
Home page world Created: 01/24/2022, 10:45 p.m From: Dominik Jahn divide Valneva: French company now announces delivery date for Europe – ahead of EMA approval. In a Booster study from December 2021* there wasn’t as much positive to report as echo24.de* reported in detail. Now is closed Valneva* an omicron study came out. The manufacturer’s…
-
New Valneva Study: Omicron Efficacy Results Surprising
Home page world Created: 1/21/2022 1:36 p.m From: Dominik Jahn divide Valneva: French company now announces delivery date for Europe – ahead of EMA approval. In a Booster study from December 2021* there wasn’t as much positive to report as echo24.de* reported in detail. Now is closed Valneva* an omicron study came out. The manufacturer’s…
-
Pfizer drug shows efficacy against Omicron in laboratory
The drug reduced the risk of hospitalization or death by nearly 90% compared to placebo for high-risk patients. Pfizer’s new Covid-19 pill, Paxlovid, was effective against the Omicron variant of the coronavirus in lab tests, an encouraging early sign that the drug could be important as the strain spreads. In a statement, the company announced…
-
Pfizer: “Anti Covid pill maintains efficacy against Omicron variant”
First data on Pfizer’s antiviral pill against the Omicron variant of Sars-CoV-2. According to the company today, “the results of numerous studies show that the in vitro efficacy of nirmatrelvir”, the main protease inhibitor of the anti-Covid drug Paxlovid *, “is maintained against Omicron”. Taken together, these in vitro studies suggest that the oral antiviral…